ASND

Ascendis Pharma
ASND

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$9.51B
EV
$9.82B
Shares Outstanding
62.19M
Beta
0.54

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$212.97
P/E 2025E
-
P/Revenue 2025E
14.31x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ascendis Pharma A/S

gainify
ASND

Ascendis Pharma A/S

ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare ...

Sector

Healthcare

Industry

Biotechnology

CEO

Mikkelsen, Jan

Employees

1,017

IPO Date

2015-01-28

Headquarters

Tuborg Boulevard 12, Hellerup, Capital Region of Denmark, 2900, Denmark

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved